UFM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.621400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.237000E-01
Normal-vs-Stage2
8.290400E-01
Normal-vs-Stage3
1.437630E-01
Normal-vs-Stage4
7.975600E-01
Stage1-vs-Stage2
5.759200E-01
Stage1-vs-Stage3
3.682000E-02
Stage1-vs-Stage4
5.550000E-01
Stage2-vs-Stage3
9.719500E-02
Stage2-vs-Stage4
9.983000E-01
Stage3-vs-Stage4
1.112420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.463600E-01
Normal-vs-AfricanAmerican
6.284400E-01
Normal-vs-Asian
9.886200E-01
Caucasian-vs-AfricanAmerican
6.873000E-01
Caucasian-vs-Asian
6.968000E-01
AfricanAmerican-vs-Asian
5.815800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.799200E-01
Normal-vs-Female
8.580400E-01
Male-vs-Female
8.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.529000E-01
Normal-vs-Age(41-60Yrs)
7.734400E-01
Normal-vs-Age(61-80Yrs)
6.873000E-01
Normal-vs-Age(81-100Yrs)
4.208800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.726800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.813800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.703400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.374200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.125600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.812200E-01
Normal-vs-Daily Drinker
5.929200E-01
Normal-vs-Weekly Drinker
6.292200E-01
Normal-vs-Occasional Drinker
7.985000E-01
Normal-vs-Social Drinker
8.098600E-01
Non Drinker-vs-Daily Drinker
7.930200E-01
Non Drinker-vs-Weekly Drinker
7.520200E-01
Non Drinker-vs-Occasional Drinker
2.728100E-02
Non Drinker-vs-Social Drinker
2.007600E-01
Daily Drinker-vs-Weekly Drinker
9.496400E-01
Daily Drinker-vs-Occasional Drinker
1.288600E-01
Daily Drinker-vs-Social Drinker
2.677400E-01
Weekly Drinker-vs-Occasional Drinker
1.871560E-01
Weekly Drinker-vs-Social Drinker
3.061000E-01
Occasional Drinker-vs-Social Drinker
7.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.697000E-01
Normal-vs-Grade 2
4.198400E-03
Normal-vs-Grade 3
2.386400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.935200E-01
Grade 1-vs-Grade 3
4.250800E-01
Grade 1-vs-Grade 4
1.697000E-01
Grade 2-vs-Grade 3
4.874600E-01
Grade 2-vs-Grade 4
4.198400E-03
Grade 3-vs-Grade 4
2.386400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.918400E-01
Normal-vs-NonDiabetic
9.339800E-01
Diabetic-vs-NonDiabetic
9.719500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.853400E-01
Normal-vs-NoPancreatitis
8.405000E-01
Pancreatitis-vs-NoPancreatitis
2.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.749200E-01
Normal-vs-N1
7.829800E-01
N0-vs-N1
5.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.535800E-01
Normal-vs-TP53-NonMutant
9.683600E-01
TP53-Mutant-vs-TP53-NonMutant
4.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
